11C-acetate: a new tracer for the evaluation of hepatocellular carcinoma.

[1]  Chi-Lai Ho,et al.  11C-acetate PET imaging in hepatocellular carcinoma and other liver masses. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2]  W. Martin,et al.  Practical FDG Imaging: A Teaching File , 2002, Springer New York.

[3]  G. Mentha,et al.  Partial hepatectomy or orthotopic liver transplantation for the treatment of resectable hepatocellular carcinoma? A cost‐effectiveness perspective , 1998, Hepatology.

[4]  M E Phelps,et al.  Quantification of Glucose Utilization in Liver Metastases: Parametric Imaging of FDG Uptake with PET , 1992, Journal of computer assisted tomography.

[5]  Y. Nishimura,et al.  Monitoring liver tumor therapy with [18F]FDG positron emission tomography. , 1990, Journal of computer assisted tomography.

[6]  H. Morris,et al.  COMPARATIVE BIOCHEMISTRY OF HEPATOMAS. V. STUDIES ON AMINO ACID INCORPORATION IN LIVER TUMORS OF DIFFERENT GROWTH RATES. , 1963, Cancer research.

[7]  H. Lodish,et al.  Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. , 1987, Science.

[8]  C. Pinson,et al.  Positron emission tomography with F‐18‐fluorodeoxyglucose to evaluate the results of hepatic chemoembolization , 1996, Cancer.

[9]  M. Ozaki,et al.  Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: characterization of tumor and assessment of effect of treatment. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  Y. Yonekura,et al.  Value of fluorine-18-FDG-PET to monitor hepatocellular carcinoma after interventional therapy. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  Y Yonekura,et al.  In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[12]  M. Laeeq Khan,et al.  Positron emission tomography scanning in the evaluation of hepatocellular carcinoma. , 2000, Journal of hepatology.

[13]  M P Sandler,et al.  Evaluation of benign vs malignant hepatic lesions with positron emission tomography. , 1998, Archives of surgery.

[14]  N. K. Monakhov,et al.  Physicochemical properties and isoenzyme composition of hexokinase from normal and malignant human tissues. , 1978, Journal of the National Cancer Institute.